ciprofloxacin has been researched along with Graft-Versus-Host Disease in 15 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a single-center open-label prospective study, a total of 134 marrow transplant recipients with hematologic malignancies were randomly assigned to a bacterial decontamination medication using metronidazole and ciprofloxacin (n = 68) or ciprofloxacin alone (n = 66) during 5 weeks posttransplant." | 9.09 | Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and ( Beelen, DW; Elmaagacli, A; Hirche, H; Müller, KD; Schaefer, UW, 1999) |
| "In a single-center open-label prospective study, a total of 134 marrow transplant recipients with hematologic malignancies were randomly assigned to a bacterial decontamination medication using metronidazole and ciprofloxacin (n = 68) or ciprofloxacin alone (n = 66) during 5 weeks posttransplant." | 5.09 | Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and ( Beelen, DW; Elmaagacli, A; Hirche, H; Müller, KD; Schaefer, UW, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Daoud-Asfour, H | 1 |
| Henig, I | 1 |
| Ghersin, I | 1 |
| Rakedzon, S | 1 |
| Stern, A | 1 |
| Pitashny, M | 1 |
| Zuckerman, T | 1 |
| Bar-Yoseph, H | 1 |
| Gupta, NK | 1 |
| Masia, R | 1 |
| Gagneux-Brunon, A | 1 |
| Pillet, S | 1 |
| Laurent, B | 1 |
| Mariat, C | 1 |
| Michalet, M | 1 |
| Lucht, F | 1 |
| Botelho-Nevers, E | 1 |
| Baluch, A | 1 |
| Pasikhova, Y | 1 |
| Snyder, M | 1 |
| Brandon, JA | 1 |
| Jennings, CD | 1 |
| Kaplan, AM | 1 |
| Bryson, JS | 1 |
| Bousquet, A | 1 |
| Demoures, T | 1 |
| Malfuson, JV | 1 |
| Martinaud, C | 1 |
| Soler, C | 1 |
| Li, HW | 1 |
| Sachs, J | 1 |
| Pichardo, C | 1 |
| Bronson, R | 1 |
| Zhao, G | 1 |
| Sykes, M | 1 |
| Trifilio, SM | 1 |
| Pi, J | 1 |
| Mehta, J | 1 |
| Yuen, KY | 1 |
| Woo, PC | 1 |
| Mays, SR | 1 |
| Kunishige, JH | 1 |
| Truong, E | 1 |
| Kontoyiannis, DP | 1 |
| Hymes, SR | 1 |
| Hagensee, ME | 1 |
| Benyunes, M | 1 |
| Miller, JA | 1 |
| Spach, DH | 1 |
| Styler, MJ | 1 |
| Crilley, P | 1 |
| Biggs, J | 1 |
| Moul, J | 1 |
| Copelan, E | 1 |
| Topolsky, D | 1 |
| Avalos, B | 1 |
| Penza, S | 1 |
| Sabol, P | 1 |
| Downs, K | 1 |
| Szer, J | 1 |
| Brodsky, I | 1 |
| Marks, DI | 1 |
| Ferrà, C | 1 |
| de Sanjosé, S | 1 |
| Lastra, CF | 1 |
| Martí, F | 1 |
| Mariño, EL | 1 |
| Sureda, A | 1 |
| Brunet, S | 1 |
| Gallardo, D | 1 |
| Berlanga, JJ | 1 |
| García, J | 1 |
| Grañena, A | 1 |
| Carlens, S | 1 |
| Ringdén, O | 1 |
| Aschan, J | 1 |
| Hägglund, H | 1 |
| Ljungman, P | 1 |
| Mattsson, J | 1 |
| Remberger, M | 1 |
| Beelen, DW | 1 |
| Elmaagacli, A | 1 |
| Müller, KD | 1 |
| Hirche, H | 1 |
| Schaefer, UW | 1 |
3 reviews available for ciprofloxacin and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Changing epidemiology of Clostridium difficile-associated disease during stem cell transplantation.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Aztreonam; Chicago; Ciprofloxacin; Clostridioides d | 2013 |
Tuberculosis in blood and marrow transplant recipients.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Bone Marrow Transplantation; Ciprofloxacin; Female; Graft vs | 2002 |
Approach to the morbilliform eruption in the hematopoietic transplant patient.
Topics: Antineoplastic Agents; Ciprofloxacin; Diagnosis, Differential; Exanthema; Graft vs Host Disease; Hem | 2007 |
2 trials available for ciprofloxacin and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications.
Topics: Adolescent; Adult; Anti-Infective Agents; Anti-Inflammatory Agents; Bacterial Infections; Bone Marro | 1997 |
Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bone Marrow Transplantation; Ciprofloxacin; Drug Therapy, | 1999 |
10 other studies available for ciprofloxacin and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Omitting Ciprofloxacin Prophylaxis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation and Its Impact on Clinical Outcomes and Microbiome Structure.
Topics: Ciprofloxacin; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Microbiota; N | 2022 |
Cord colitis syndrome: a cause of granulomatous inflammation in the upper and lower gastrointestinal tract.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Colitis; Cord Blood Stem Cell Transplantation; Crohn Di | 2013 |
A case of BK virus nephropathy in a stem cell transplant recipient: a rare or under-recognized cause for Acute Kidney injury.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; BK Virus; Ciprofloxacin; Cord Blood Stem Cell Transplant | 2015 |
Successful management of Mycobacterium haemophilum lower extremity cutaneous infection in a matched-unrelated donor stem cell transplant recipient.
Topics: Anti-Bacterial Agents; Biopsy; Cellulitis; Ciprofloxacin; Clarithromycin; Female; Graft vs Host Dise | 2017 |
Murine syngeneic graft-versus-host disease is responsive to broad-spectrum antibiotic therapy.
Topics: Animals; Anti-Bacterial Agents; Bone Marrow Transplantation; CD4-Positive T-Lymphocytes; Cell Line; | 2011 |
Campylobacter jejuni cutaneous infection in a patient with graft versus host disease.
Topics: Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Erysipelas; Graft vs Host Disease; He | 2012 |
Nonalloreactive T cells prevent donor lymphocyte infusion-induced graft-versus-host disease by controlling microbial stimuli.
Topics: Animals; Ciprofloxacin; Graft vs Host Disease; Inflammation; Lymphocyte Transfusion; Lymphopenia; Me | 2012 |
Campylobacter jejuni bacteremia and Guillain-Barré syndrome in a patient with GVHD after allogeneic BMT.
Topics: Bacteremia; Bone Marrow Transplantation; Campylobacter Infections; Campylobacter jejuni; Ciprofloxac | 1994 |
Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bone Marrow Transplantation; Busulfan; Child; Child, | 1996 |
Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
Topics: Adult; Anti-Infective Agents; Bone Marrow Transplantation; Ciprofloxacin; Cyclophosphamide; Disease- | 1998 |